Direktorat Registrasi ObatValid

GLIMEPIRIDE

by '-'

Claim this product
BPOM Number
GKL1212425810D1
Approved
10 January 2025
Expiry
14 April 2027
Form
Tablet

About This Registration

GLIMEPIRIDE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1212425810D1. Its current registration status is Valid, with the licence valid until 14 April 2027. The product is registered to KIMIA FARMA TBK. - INDONESIA. BPOM first approved this registration in April 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 5 STRIP @ 10 TABLET
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Market Intelligence

Owner Portfolio
KIMIA FARMA TBK. - INDONESIA holds 354 BPOM registrations
Manufacturer Scale
KIMIA FARMA TBK. - INDONESIA produces 354 registered products
Registration Age
Registered for 4 years, 3 months
Expiry Status
Expires in 9 months

FDA Cross-Reference

via openFDA
Generic Name
GLIMEPIRIDE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from KIMIA FARMA TBK. - INDONESIA

KIFAROX

-DKL2644412109A1
Valid
Approved: Apr 24, 2026KAPLET SALUT SELAPUT
View product →

CIPROFLOXACIN HYDROCHLORIDE

-GKL2644412209A1
Valid
Approved: Apr 24, 2026KAPLET SALUT SELAPUT
View product →

RESQUILINE

-DKI2571000110A1
Valid
Approved: Dec 10, 2025TABLET
View product →

GLIMEPIRIDE

-GKL2544412010A1
Valid
Approved: Nov 12, 2025TABLET
View product →

ACETYLSALICYLIC ACID

-GKL2544411915A1
Valid
Approved: Nov 10, 2025TABLET SALUT ENTERIK
View product →

Products in the same class

SIMTROBAN

-DKL2228211629A1
Valid
Approved: Mar 31, 2026KRIM
SIMEX PHARMACEUTICAL INDONESIA - INDONESIA
View product →

IBANDRONIC SODIUM MONOHYDRATE

-GKL1833542243A1
Valid
Approved: Aug 27, 2025INJEKSI
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

NORAGES

-DKL0615619543A1
Valid
Approved: May 16, 2025INJEKSI
MEPROFARM
View product →

HOLIDON

-DBL9917106904A1
Valid
Approved: Feb 26, 2025KAPLET
HOLI PHARMA - INDONESIA
View product →

SIKZONOATE

-DKI1034100143A1
Valid
Approved: Feb 20, 2025INJEKSI
MERSIFARMA TIRMAKU MERCUSANA
View product →
1